GAM
ZBH icon

Generali Asset Management’s Zimmer Biomet ZBH Stock Holding History

Generali Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Hold
15,317
– – 0.02% 319
2026
Q1 		$1.38M Buy
15,317
+360
+2% +$33K 0.03% 360
2025
Q4 		$1.34M Buy
14,957
+725
+5% +$68.7K 0.03% 371
2025
Q3 		$1.4M Buy
14,232
+122
+0.9% +$12.1K 0.03% 368
2025
Q2 		$1.29M Buy
14,110
+2,042
+17% +$197K 0.03% 388
2025
Q1 		$1.37M Sell
12,068
-27,280
-69% -$2.92M 0.03% 361
2024
Q4 		$4.16M Buy
+39,348
New +$4.22M 0.11% 185

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Generali Asset Management's ZBH Position: Q2 2026 in Review

Generali Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 15,317 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #319.

Generali Asset Management first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.16M in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Generali Asset Management held 15,317 shares of Zimmer Biomet worth $1.32M as of Q2 2026.
  • Generali Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.02% of Generali Asset Management's portfolio in Q2 2026, its #319 holding.
  • Generali Asset Management first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Zimmer Biomet position peaked at $4.16M in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.